NTT DATA Expands Collaboration with Google Cloud to Accelerate Enterprise AI from Pilots to Production
8.6.2026 14:00:00 CEST | Business Wire | Press release
Collaboration combines Gemini Enterpriseand NTT DATA services across strategy, implementation, adoption and managed services NTT DATA will establish a Gemini Enterprise practice, targeting 5,000 certified experts NTT DATA and Google Cloud will co-innovate and deploy up to 500 AI agents across industry use cases
NTT DATA, a global leader in AI, digital business and technology services today announced an expanded collaboration with Google Cloud to help enterprises move from AI experimentation to scaled deployment of agentic AI solutions built with Gemini Enterprise. The collaboration is focused on enabling AI-powered reinvention, helping enterprises redesign processes, operating models and customer experiences using agentic AI.
The collaboration combines Google Cloud’s AI, data and cloud platform capabilities with NTT DATA’s global delivery scale and deep industry expertise across strategy, implementation, adoption, managed services and value realization. Together, the companies will help clients embed AI into core workflows, improve productivity, accelerate time-to-value and support governance, security, compliance and responsible use of AI.
NTT DATA is establishing a dedicated global Gemini Enterprise practice, backed by joint business planning, technical enablement, training, certifications, engineering support and coordinated go-to-market investments. NTT DATA aims to certify 5,000 Gemini Enterprise experts globally.
The NTT DATA Gemini Enterprise practice will help clients accelerate deployment, deepen adoption and create more repeatable paths to business value with Gemini Enterprise. This includes a joint roadmap to co-innovate up to 500 AI agents across horizontal and industry-specific enterprise use cases, creating reusable building blocks for rapid, scalable AI adoption.
NTT DATA will rapidly design, build and deploy AI solutions across enterprise workflows. This expanded collaboration with Google Cloud represents a new model for enterprise AI deployment, combining platform innovation, engineering depth and industry expertise into a single integrated approach.
The companies will enable thousands of AI-skilled engineers, “forward-deployed engineers” embedded directly with clients, alongside industry domain experts, forming integrated co-innovation teams to deliver enterprise-scale AI solutions. These teams will work directly with clients to accelerate solution development, support deployments and address complex technical challenges in real-time, reducing time-to-value and accelerating production adoption.
The initiative will support the development of AI agents across a broad range of industry, IT and domain services, including re-imagining business processes in banking, insurance, manufacturing and retail, accelerating cloud migration and software development and optimizing marketing performance, procurement and finance operations.
Key components of the program include:
- Industrialized agent development and deployment: A global factory model that combines reusable assets, engineering talent and co-innovation pipelines to design, build and scale AI agents across enterprise workflows.
- Dedicated joint engineering and innovation teams: Integrated teams of NTT DATA experts and Google Cloud engineers working side by side to prototype, produce and scale high-value use cases.
- Sovereign, secure and compliant AI by design: Support for sovereign AI deployments that meet data residency, regulatory and compliance requirements, leveraging Google Cloud capabilities alongside NTT DATA’s global leadership in data centers and managed services.
- Pre-built and industry-specific agent solutions: A growing catalog of reusable, industry specific AI agents and accelerators to speed deployment, reduce risk and accelerate time-to-value.
“Enterprises need a practical way to scale AI adoption, strengthen governance, enable their workforce and create measurable business value,” said Abhijit Dubey, CEO and Chief AI Officer, NTT DATA, Inc. “This expanded partnership with Google Cloud and NTT DATA is helping clients move beyond pilots and embed AI into the way their organizations operate, creating a faster and lower-risk path to enterprise-wide transformation.”
"We are seeing massive demand for AI agents that can fundamentally transform core business workflows,” said Matt Renner, President and Chief Revenue Officer, Google Cloud. “This expanded partnership combines Google Cloud’s leading AI platform with NTT DATA’s delivery strength. By developing hundreds of agents and training thousands of experts, NTT DATA is ensuring our joint customers have the specialized resources required to deploy sophisticated AI solutions at a global scale."
Many organizations have made progress with AI, but fewer have scaled it across the enterprise in ways that change how work gets done. The challenge goes beyond technology access and includes governance, workforce enablement, use-case prioritization, rollout planning and the ability to connect adoption to business outcomes.
According to a recent NTT DATA client survey, 99% of enterprises say AI is driving greater demand for cloud investment. At the same time, 88% report that current cloud investment levels are putting AI, cloud-native and modernization initiatives at risk. NTT DATA’s expanded work with Google Cloud is designed to help close that gap by aligning AI ambition with the scalable, secure cloud infrastructure required to deliver results.
About NTT DATA
NTT DATA is a $30+ billion business and technology services leader, serving 75% of the Fortune Global 100. We are committed to accelerating client success and positively impacting society through responsible innovation. We are one of the world’s leading AI and digital infrastructure providers, with unmatched capabilities in enterprise-scale AI, cloud, security, connectivity, data centers and application services. Our consulting and industry solutions help organizations and society move confidently and sustainably into the digital future. As a Global Top Employer, we have experts in more than 70 countries. We also offer clients access to a robust ecosystem of innovation centers as well as established and start-up partners. NTT DATA is part of NTT Group, which invests over $3 billion each year in R&D.
Visit us at nttdata.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260608420229/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership4.8.2026 11:00:00 CEST | Press release
The integration gives eligible WHOOP members seamless access to the only FDA-cleared hormone-free birth control app, with the first year of Natural Cycles° included for those new to the app as part of their WHOOP membership. WHOOP, the human performance company, today announced an expansion of its women’s health offering through an integration with Natural Cycles° (NC°), the only FDA-cleared, hormone-free birth control app. WHOOP is offering a 12-month subscription to the NC° app to eligible new Natural Cycles users. Members with compatible WHOOP devices can now automatically share overnight skin temperature with the NC° app to enable personalized fertility insights and hormone-free birth control. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804399367/en/ WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership The Natural Cycles app, a Class II medical device, u
Alphatax Makes Two Acquisitions to Strengthen Transfer Pricing Capabilities4.8.2026 10:00:00 CEST | Press release
Acquisitions Expand Transfer Pricing Offering and Support Long-Term Platform Strategy Alphatax, the global tax compliance software provider, has today announced the acquisitions of TP Accurate and Intra Pricing Solutions, expanding its transfer pricing capabilities and reinforcing its ambition to build the world's first tax operating system. The acquisitions strengthen Alphatax's transfer pricing portfolio with complementary capabilities across financial transactions and documentation. TP Accurate provides specialist software for intra-group financing arrangements, while Intra Pricing Solutions' flagship product, TPGenie, enables multinational organisations and advisors to produce transfer pricing documentation using intelligent automation and AI. Together, they expand Alphatax's ability to support the full transfer pricing lifecycle, helping customers manage compliance more efficiently while improving governance and reducing audit risk. They also represent another step towards Alphata
LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care4.8.2026 09:10:00 CEST | Press release
LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3 KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5 The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The
“HATSUNE MIKU LIGHTS TOKYO” Debuts on July 254.8.2026 09:00:00 CEST | Press release
Giant Hatsune Miku Returns to Light Up Tokyo’s Night! The Tokyo Metropolitan Government has been presenting year-round projection mapping displays on the Tokyo Metropolitan Government Building, using light and sound to showcase a wide range of artistic expressions as part of its efforts to create new nighttime tourism attractions in Tokyo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260802298570/en/ © Crypton Future Media, INC. On Saturday, July 25, "HATSUNE MIKU LIGHTS TOKYO", featuring the globally beloved virtual singer Hatsune Miku, held its first screening. The work brings the world of the popular song “M@GICAL☆CURE! LOVE ♥ SHOT!” to life across the entire façade of the Tokyo Metropolitan Government Building. Since its launch in February 2024, “TOKYO Night & Light” has welcomed visitors from Japan and around the world, with total attendance surpassing 1.55 million. As one of Tokyo’s emerging landmark attractions, the
Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board4.8.2026 09:00:00 CEST | Press release
Accomplished life sciences leader with a proven track record of driving successful development of novel therapeutics, joins Mosaic to guide its next phase of growthAllison brings three decades of drug development, board and executive leadership experience to support Mosaic’s transition towards a clinical-stage company Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life sciences leader, and brings over three decades of drug development and executive experience to Mosaic Therapeutics. As CEO of Avillion, a clinical development company, for the last 13 year
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom